Hattori T, Fujitsuka N, Shindo S
Central Laboratories, Tsumura & Co. Ibaraki, Japan.
Nihon Jinzo Gakkai Shi. 1996 May;38(5):202-12.
We investigated whether acteoside can inhibit mesangial matrix expansion or mesangial cell proliferation in mesangioproliferative anti-Thy 1 nephritis. Untreated control rats were compared to the rats treated with acteoside either during early (day 1 to 8) or late (day 4 to 12) period after the induction of anti-Thy 1 nephritis. The result showed that acteoside and prednisolone treatments (in either early or late period) significantly reduced proteinuria, mesangial matrix expansion (the index of matrix expansion) and mesangial proliferation as determined by the number of proliferating nuclear cell antigen (PCNA)-positive cells. Acteoside also reduced glomerular macrophage infiltration and ICAM-1 expression in glomeruli of anti-Thy 1 nephritic rats. Furthermore, acteoside treatment markedly increased the activities of matrix metaloproteinases (MMP) in glomeruli. These results suggest that acteoside can inhibit mesangial cell proliferation and extracellular matrix overproduction by either inhibiting ICAM-1 expression or increasing activities of MMP.
我们研究了毛蕊花糖苷是否能抑制系膜增生性抗Thy 1肾炎中的系膜基质扩张或系膜细胞增殖。将未经治疗的对照大鼠与在抗Thy 1肾炎诱导后的早期(第1天至第8天)或晚期(第4天至第12天)用毛蕊花糖苷治疗的大鼠进行比较。结果显示,毛蕊花糖苷和泼尼松龙治疗(早期或晚期)均显著降低蛋白尿、系膜基质扩张(基质扩张指数)以及通过增殖细胞核抗原(PCNA)阳性细胞数量确定的系膜增殖。毛蕊花糖苷还减少了抗Thy 1肾炎大鼠肾小球中的巨噬细胞浸润和ICAM - 1表达。此外,毛蕊花糖苷治疗显著增加了肾小球中基质金属蛋白酶(MMP)的活性。这些结果表明,毛蕊花糖苷可通过抑制ICAM - 1表达或增加MMP活性来抑制系膜细胞增殖和细胞外基质过度产生。